Sanofi, GSK nab $2.1B deal from federal government to provide Covid-19 vaccine

  • by

The companies will provide 100 million doses of their jointly developed vaccine. But with a Phase I/II study planned in September, it is behind in development compared with those of Moderna and Pfizer and BioNTech, which have already started late-stage clinical testing.